Mantle cell lymphoma involving the oral and maxillofacial region: a study of 20 cases

被引:2
作者
Ribeiro Carvalho, Marcus Vinicius [1 ]
Rodrigues-Fernandes, Carla Isabelly [1 ]
Lopez de Caceres, Cinthia Veronica Bardalez [1 ]
Mesquita, Ricardo Alves [2 ]
Martins, Manoela Domingues [3 ]
Jose Roman Tager, Elena Maria [1 ,4 ]
Carlos, Roman [4 ]
Pires, Fabio Ramoa [5 ]
Robinson, Liam [6 ]
van Heerden, Willie F. P. [6 ]
Valente, Vitor Bonetti [7 ]
Caldeira Xavier-Junior, Jose Candido [8 ,9 ]
Bernabe, Daniel Galera [7 ]
Rebelo Pontes, Helder Antonio [10 ]
Soares, Ciro Dantas [11 ]
Melo da Costa, Mauro Henrique
Vargas, Pablo Agustin [1 ,6 ]
Fonseca, Felipe Paiva [1 ,2 ,6 ]
机构
[1] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Oral Diag, Piracicaba, Brazil
[2] Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, Belo Horizonte, MG, Brazil
[3] Univ Fed Rio Grande do Sul, Dept Oral Pathol, Sch Dent, Porto Alegre, RS, Brazil
[4] Hosp Herrera Llerandi, Pathol Sect, Ctr Clin Cabeza & Cuello, Guatemala City, Guatemala
[5] Univ Estado Rio De Janeiro, Dent Sch, Oral Pathol, Rio De Janeiro, Brazil
[6] Univ Pretoria, Fac Hlth Sci, Sch Dent, Dept Oral Pathol & Oral Biol, Pretoria, South Africa
[7] Sao Paulo State Univ UNESP, Oral Oncol Ctr, Sch Dent, Aracatuba, Brazil
[8] Ctr Univ Catolico Unisalesiano Auxilium, Pathol, Inst Aracatuba, Aracatuba, Brazil
[9] Ctr Univ Catolico Unisalesiano Auxilium, Sch Med, Aracatuba, Brazil
[10] Fed Univ Para, Joao de Banos Barreto Univ Hosp, Oral Pathol Serv, Belem, Para, Brazil
[11] Getulio Sales Diagnost, Natal, RN, Brazil
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 2023年 / 135卷 / 01期
基金
巴西圣保罗研究基金会;
关键词
SURVIVAL; INDEX;
D O I
10.1016/j.oooo.2022.08.018
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective. To investigate the clinicopathologic features of mantle cell lymphoma (MCL) involving the oral and maxillofacial region. Methods. The MCL cases were retrieved from the pathosis database of 6 pathology laboratories. Original hematoxylin and eosin slides and immunohistochemical reactions were reviewed for confirmation of the initial diagnosis. Clinical data of the cases were obtained from the patients' pathosis and/or medical charts. Results. Twenty cases were included in the study, showing a male predominance and a mean age of 66 years. The oral cavity (12 cases) and the oropharynx (5 cases) were the most commonly involved subsites. Most cases presented as asymptomatic swellings, with 2 cases showing bilateral involvement of the palate. The classic histologic variant predominated (12/20 cases). All cases expressed CD20 with nuclear cyclin D1 positivity. SOX11 was seen in 9/13 cases, CD5 in 6/16 cases, Bcl2 in 16/19 cases, CD10 in 2/20 cases, and Bcl6 in 4/16 cases. Ki67 showed a mean proliferation index of 40.6%. The Epstein-Barr virus (EBV) was negative in all cases investigated. Follow-up data was available for 7 patients, with 5 currently alive and 2 deceased. Conclusion. Mantle cell lymphoma, albeit rare, may manifest in the oral and maxillofacial region. Its histologic heterogeneity demands a high degree of diagnostic skill from pathologists. (Oral Surg Oral Med Oral Pathol Oral Radiol 2023;135:101-109)
引用
收藏
页码:101 / 109
页数:9
相关论文
共 50 条
  • [41] SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study
    Nordstrom, Lena
    Sernbo, Sandra
    Eden, Patrik
    Gronbaek, Kirsten
    Kolstad, Arne
    Raty, Riikka
    Karjalainen, Marja-Liisa
    Geisler, Christian
    Ralfkiaer, Elisabeth
    Sundstrom, Christer
    Laurell, Anna
    Delabie, Jan
    Ehinger, Mats
    Jerkeman, Mats
    Ek, Sara
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (01) : 98 - 108
  • [42] Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases
    Rodrigues, P. C.
    Miguel, M. C. C.
    Bagordakis, E.
    Fonseca, F. P.
    de Aquino, S. N.
    Santos-Silva, A. R.
    Lopes, M. A.
    Graner, E.
    Salo, T.
    Kowalski, L. P.
    Coletta, R. D.
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2014, 43 (07) : 795 - 801
  • [43] Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
    Song, Yuqin
    Zhou, Keshu
    Zou, Dehui
    Zhou, Jianfeng
    Hu, Jianda
    Yang, Haiyan
    Zhang, Huilai
    Ji, Jie
    Xu, Wei
    Jin, Jie
    Lv, Fangfang
    Feng, Ru
    Gao, Sujun
    Guo, Haiyi
    Zhou, Lei
    Huang, Jane
    Novotny, William
    Kim, Pil
    Yu, Yiling
    Wu, Binghao
    Zhu, Jun
    [J]. BLOOD, 2022, 139 (21) : 3148 - 3158
  • [44] Comorbidities and sex differences in causes of death among mantle cell lymphoma patients - A nationwide population-based cohort study
    Glimelius, Ingrid
    Smedby, Karin E.
    Eloranta, Sandra
    Jerkeman, Mats
    Weibull, Caroline E.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (01) : 106 - 116
  • [45] Outcomes for Recurrent Mantle Cell Lymphoma Post-Ibrutinib Therapy: A Retrospective Cohort Study from a Japanese Administrative Database
    Rai, Shinya
    Tanizawa, Yoshinori
    Cai, Zhihong
    Huang, Yu-Jing
    Taipale, Kaisa
    Tajimi, Masaomi
    [J]. ADVANCES IN THERAPY, 2022, 39 (10) : 4792 - 4807
  • [46] Characteristics of oral squamous cell carcinoma focusing on cases unaffected by smoking and drinking: A multicenter retrospective study
    Harada, Hiroyuki
    Kikuchi, Masahiro
    Asato, Ryo
    Hamaguchi, Kiyomi
    Tamaki, Hisanobu
    Mizuta, Masanobu
    Hori, Ryusuke
    Kojima, Tsuyoshi
    Honda, Keigo
    Tsujimura, Takashi
    Kumabe, Yohei
    Ichimaru, Kazuyuki
    Kitani, Yoshiharu
    Ushiro, Koji
    Kitamura, Morimasa
    Shinohara, Shogo
    Omori, Koichi
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (07): : 1812 - 1822
  • [47] Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
    Goy, A.
    Bernstein, S. H.
    Kahl, B. S.
    Djulbegovic, B.
    Robertson, M. J.
    de Vos, S.
    Epner, E.
    Krishnan, A.
    Leonard, J. P.
    Lonial, S.
    Nasta, S.
    O'Connor, O. A.
    Shi, H.
    Boral, A. L.
    Fisher, R. I.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (03) : 520 - 525
  • [48] The Value of Bone Marrow Assessment by FDG PET/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort Study
    Quinonero, Isabel Rodenas
    Marco-Ayala, Javier
    Chen-Liang, Tzu-Hua
    de la Cruz-vicente, Fatima
    Baumann, Tycho
    Navarro, Jose-Tomas
    Garcia-Sancho, Alejandro Martin
    Martin-Santos, Taida
    Lopez-Jimenez, Javier
    Andreu, Rafael
    Parra, Ester
    Usas, Andrea
    Alonso, David
    Fernandez-Gonzalez, Marta
    Rumschisky, Pablo Palomo
    Frutos, Laura
    Navarro, Jose Luis
    Alvarez-Perez, Rosa Maria
    Sarandeses, Pilar
    Cortes, Montserrat
    Tamayo, Pilar
    Una, Jon
    Martinez-Lorca, Alberto
    Ruiz, Cristina
    Lozano, Maria Luisa
    Ortuno, Francisco Jose
    [J]. CANCERS, 2024, 16 (24)
  • [49] Bortezomib in combination with fludarabine plus cyclophosphamide for patients with relapsed or refractory mantle-cell lymphoma: results of the LYM-4003 study
    Wang, Xiao-Xiao
    Gao, Yan
    Jin, Jie
    Cao, Jun-Ning
    Feng, Ji-Feng
    Wang, Hua-Qing
    Zhang, Hui-Lai
    Cai, Qing-Qing
    Li, Zhi-Ming
    Jiang, Wen-Qi
    Huang, Hui-Qiang
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (12) : 2961 - 2968
  • [50] A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma
    Dreyling, Martin
    Tam, Constantine S.
    Wang, Michael
    Smith, Stephen D.
    Ladetto, Marco
    Huang, Huiqiang
    Novotny, William
    Co, Melannie
    Romano, Alfredo
    Holmgren, Eric
    Huang, Jane
    Le Gouill, Steven
    [J]. FUTURE ONCOLOGY, 2021, 17 (03) : 255 - 262